Citadel Advisors’s National Healthcare NHC Stock Holding History

Citadel Advisors’s Portfolio NHC Stock Details NHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,300	Closed	-$522K	–	13614
2025 Q3	$522K	Buy	+4,300	New	+$464K	﹤0.01%	9021

Other funds holding NHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

MSIIA

Morgan Stanley Institutional Investment Advisors Greenwood Village, Colorado $1.07B AUM 29.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Citadel Advisors's NHC Position: Q2 2026 in Review

Citadel Advisors sold out of National Healthcare (NHC) in Q2 2026, closing a stake of 7,942 shares — an estimated $1.46M sold.

Citadel Advisors first reported a position in NHC in Q4 2015 and held it in 30 quarters. The position peaked at $5.84M in Q1 2023. 249 funds tracked by Wall St. Rank hold NHC as of Q2 2026.

Citadel Advisors reported no remaining National Healthcare position as of Q2 2026 after selling out during the quarter.
Citadel Advisors sold 7,942 National Healthcare shares in Q2 2026, an estimated $1.46M.
Citadel Advisors first reported a position in National Healthcare in Q4 2015 and held it in 30 quarters.
Citadel Advisors's National Healthcare position peaked at $5.84M in Q1 2023.
249 funds tracked by Wall St. Rank held National Healthcare as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.